Rapport Therapeutics, Inc. Common Stock

RAPP

$47.65

-2.14%

N/A-$1.04

Healthcare

Biotechnology

NASDAQ

Negociación activa

Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living ...

Transacciones de insiders de RAPP

Compras (A)

Since Aug 10, 2026

Ventas (D)

Since Aug 10, 2026

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Resumen de trading de insiders

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio
Aug 25, 2026	Ceesay Abraham	director, officer: Chief Executive Officer	Common Stock	D	18,921	$49.57
Aug 25, 2026	Yeleswaram Krishnaswamy	officer: Chief Development Officer	Common Stock	D	20,799	$50.31
Aug 25, 2026	Yeleswaram Krishnaswamy	officer: Chief Development Officer	Common Stock	D	16,201	$51.06
Aug 24, 2026	Yeleswaram Krishnaswamy	officer: Chief Development Officer	Common Stock	D	13,160	$50.00
Aug 19, 2026	Yeleswaram Krishnaswamy	officer: Chief Development Officer	Common Stock	D	404	$49.90

Resumen de trading de insiders

Compras (A)

Ventas (D)

Acciones compradas totales

Acciones vendidas totales

120,984

Actividad mensual de insiders

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Por cargo - Acciones

Eje X: acciones, ordenado por acciones totales desc.

Por cargo - Conteos

Eje X: conteos, ordenado por conteos A+D desc.

Personas clave: actividad de compra/venta y precio

Ceesay Abraham

director, officer: Chief Executive Officer • 6 transacciones

Yeleswaram Krishnaswamy

officer: Chief Development Officer • 4 transacciones

Tabla de transacciones

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio	Valor
Aug 25, 2026	Ceesay Abraham	director, officer: Chief Executive Officer	Common Stock	D	18,921	$49.57	$937,957.49
Aug 25, 2026	Yeleswaram Krishnaswamy	officer: Chief Development Officer	Common Stock	D	20,799	$50.31	$1,046,420.57
Aug 25, 2026	Yeleswaram Krishnaswamy	officer: Chief Development Officer	Common Stock	D	16,201	$51.06	$827,184.18
Aug 24, 2026	Yeleswaram Krishnaswamy	officer: Chief Development Officer	Common Stock	D	13,160	$50.00	$657,977.63
Aug 19, 2026	Yeleswaram Krishnaswamy	officer: Chief Development Officer	Common Stock	D	404	$49.90	$20,159.60
Aug 11, 2026	Ceesay Abraham	director, officer: Chief Executive Officer	Common Stock	D	3,664	$46.90	$171,837.20
Aug 11, 2026	Ceesay Abraham	director, officer: Chief Executive Officer	Common Stock	D	19,500	$48.04	$936,846.30
Aug 11, 2026	Ceesay Abraham	director, officer: Chief Executive Officer	Common Stock	D	5,794	$48.62	$281,721.08
Aug 10, 2026	Ceesay Abraham	director, officer: Chief Executive Officer	Common Stock	D	14,171	$45.97	$651,491.89
Aug 10, 2026	Ceesay Abraham	director, officer: Chief Executive Officer	Common Stock	D	8,370	$46.75	$391,279.92

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal